The synthesis of C8-Aryl purines, nucleosides, and phosphoramidites

Critical Reviews in Eukaryotic Gene Expression

Volumn 21, Issue 2, 2011, Pages 155-176

  Thomsen, Nissa M ^a   Vongsutilers, Vorasit ^b   Gannett, Peter M ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

C8 aryl purines; Modified oligonucleotides synthesis; Phosphoramidites; Suzuki cross coupling reaction; Therapeutics

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; IMIDAZOLE; NUCLEOSIDE; OLIGONUCLEOTIDE; PHOSPHORAMIDOUS ACID; PURINE; PURINE DERIVATIVE; PURINE NUCLEOSIDE; PYRIMIDINE;

ARTICLE; ARYLATION; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONFORMATION; CROSS COUPLING REACTION; DRUG DESIGN; FLUORESCENCE; MOLECULAR PROBE; PRIORITY JOURNAL; SUBSTITUTION REACTION; SUZUKI REACTION; SYNTHESIS;

EID: 80755136759     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v21.i2.50     Document Type: Article

References (79)

1. Gudmundsson KS, Daluge SM, Condreay LD, Johnson LC. Synthesis of novel 8-substituted carbocyclic analogs of 2′,3′-dideoxyadenosine with activity against hepatitis B virus. Nucleosides, Nucleotides Nucleic Acids. 2002;21(11/12):891-901.
2. Kanda T, Jackson MJ, Smith LA, Pearce RK, Nakamura J, Kase H, Kuwana Y, Jenner P. Adenosine A2A antagonists: a novel antiparkinson agent that does not provoke dyskinesia in Parkinsonian monkeys. Ann Neurol. 1998;43:507-13.
3. Strouse JJ, Jeselnik M, Arterburn JB. Applications of boronic acids in selective C-C and C-N arylation of purines. Acta Chim Slov. 2005;52:187-99.
4. Williams MC, Jarvis MF. Purinergic and pyrimidinergic receptors as potential drug targets. Biochem Pharmacol. 2000;59:1173-85.
5. Gannett PM, Heavner S, Daft JR, Shaughnessy KH, Epperson JD, Greenbaum NL. Synthesis, properties, and NMR studies of a C8-phenylguanine modified oligonucleotide that preferentially adopts the Z-DNA conformation. Chem Res Toxicol. 2003;16:1385-94.
6. Heavner S, Gannett PM. Molecular dynamics and free energy calculations of the B and Z forms of C8-arylguanine modified oligonucleotides. J Biomol Str Dyn. 2005;23(2):203-19.
7. Nair V, Young DA. Conformational correlation of purine nucleosides by high-field carbon-13 NMR data. Magn Res Chem. 1987;25:937-40.
8. Uesugi S, Ikehara M. Carbon-13 magnetic resonance spectra of 8-substituted purine nucleosides. Characteristic shifts for the syn conformation. J Am Chem Soc. 1977;99:3250-3.
9. Bookser BC, Matelich MC, Ollis K, Ugarkar BG. Adenosine kinase inhibitors. 4. 6,8-Disubstituted purine nucleoside derivatives. Synthesis, conformation, and enzyme inhibition. J Med Chem. 2005;48:3389-99.
10. Vongsutilers V, Phillips DJ, Train BC, McKelvey GR, Thomsen NM, Shaughnessy KH, Lewis JP, Gannett PM. The effect of C8-arylguanine adducts on the B/Z-DNA equilibriuim and the potential role of Z-DNA in aryl hydrazine carcinogenesis. Biophys Chem. 2011;154(1):41-8.
11. Giorgi T, Lena S, Mariani P, Cremonini MA, Masiero S, Pieraccini S, Rabe JP, Samorì P, Spada GP, Gottarelli G. Supramolecular helices via self-assembly of 8-oxoguanosines. J Am Chem Soc. 2003;125:14741-9.
12. Dai Q, Xu D, Lim K, Harvey RG. Efficient syntheses of C8-aryl adducts of adenine and guanine formed by reaction of radical cation metabolites of carcinogenic polycyclic aromatic hydrocarbons with DNA. J Org Chem. 2007;72:4856-63.
13. Harvey RG, Dai Q, Ran C, Lim K. Synthesis of adducts of active metabolites of carcinogenic polycyclic aromatic hydrocarbons with 2′-deoxyribonucleosides. Polycyclic Aromat. Compd. 2005;25:371-91.
14. Ryabukhin SV, Plaskon AS, Volochnyuk DM, Tolmachev AA. Synthesis of fused imidazoles and benzothiazoles from (hetero)aromatic ortho-diamines or orthoaminothiophenol and aldehydes promoted by chlorotrimethylsilane. Synthesis. 2006;(21):3715-26.
15. Dong M, Sitkovsky M, Kallmerten AE, Jones GB. Synthesis of 8-substituted xanthines via 5,6-diaminouracils: an efficient route to A2A adenosine receptor antagonists. Tetrahed Lett. 2008;49:4633-5.
16. Elion GB, Burgi E, Hitchings GH. Studies on condensed pyrimidine systems. VII. Some 8-arylpurines. J Am Chem Soc. 1951;73:5235-9.
17. Lucas B, Rosen N, Chiosis G. Facile synthesis of a library of 9-alkyl-8-benzyl-9H-purin-6-ylamine derivatives. J Comb Chem. 2001;3:518-20.
18. Muller CE, Thorand M, Qurishi R, Diekmann M, Jacobson KA, Padgett WL, Daly JW. Imidazo[2,1-i] purin-5-ones and related tricyclic water-soluble purine derivatives: potent A2A-and A3-adenosine receptor antagonists. J Med Chem. 2002;45:3440-50.
19. Kenyon CP, Oldfield LC, Van Der Westhuyzen CW, Roussear AL, Parkinson CL, inventors; CSIR, assignee. Modulation of phosphoryl transferase activity of glutamine synthetase activity of glutamine synthetase. Pretoria/South Africa patent WO 2007/105023. 2007.
20. Hung M-H, Stock LM. Reactions of benzenediazonium ions with guanine and its derivatives. J Org Chem. 1982;47:448-53.
21. Chin A, Hung M-H, Stock LM. Reactions of benzenediazonium ions with adenine and its derivatives. J Org Chem. 1981;46:2203-7.
22. Gannett PM, Lawson T, Miller M, Thakkar DD, Lord JW, Yau W-M, Toth B. 8-Arylguanine adducts from arenediazonium ions and DNA. Chem-Biol Interact. 1996;95:1-25.
23. Gannett PM, Yau W-M, Lawson T, Lord J, Kolar C, Toth B. Formation of C8-aryladenine adducts from arenediazonium ions and DNA. AACR Proc. 1997;38:A2233.
24. Gannett PM, Lawson T, Toth B. Anomalous reaction of adenine and 4-(hydroxymethyl)benzenediazonium ion. Tetrahed Lett. 1987;28:1015-8.
25. Vollmann K, Muller CE. Synthesis of 8-substituted xanthine derivatives by Suzuki cross-coupling reaction. Heterocycles. 2002;57:871-9.
26. Riva-Toniolo C, Muller S, Schaub J, Brill WKD. Catalysis of nucleophilic aromatic substitutions in the 2,6,8-trisubstituted purines and application in the synthesis of combinatorial libraries. Mol Diversity. 2003;6:43-53.
27. Schlitt KM, Sun KM, Paugh RJ, Millen AL, Navarro-Whyte L, Wetmore SD, Manderville RA. Concerning the hydrolytic stability of 8-aryl-20-deoxyguanosine nucleoside adducts: implications for abasic site formation at physiological pH. J Org Chem. 2009;74:5793-802.
28. Manfredini S, Baraldi PG, Bazzanini R, Marangoni M, Simoni D, Balzarini J, De Clercq E. Synthesis and cytotoxic activity of 6-vinyl-and 6-ethynyluridine and 8-vinyl-and 8-ethynyladenosine. J Med Chem. 1995;38:199-203.
29. Laufer SA, Domeyer DM, Scior TRF, Albrecht W, Hauser RJ. Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors. J Med Chem. 2005;48:710-22.
30. Kim Y-C, Karton Y, Ji X-D, Linden J, Jacobson KA. Acyl-hydrazide derivatives of a xanthine carboxylic congener (XCC) as selective antagonists at human A2B adenosine receptors. Drug Dev Res. 1999;47:178-88.
31. Akanni A, Abul-Hajj YJ. Estrogen-nucleic acid adducts: dissection of the reaction of 3,4-estrone quinone and its radical anion and radical cation with deoxynucleosides and DNA. Chem Res Toxicol. 1999;12:1247-53.
32. Gannett PM, Powell JH, Rao R, Shi X, Lawson T, Kolar C, Toth B. C8-Arylguanine and C8-aryladenine formation in calf thymus DNA from arenediazonium ions. Chem Res Toxicol. 1999;12(3):297-304.
33. Lynam JM. Nucleobase-containing transition metal complexes as building blocks for biological markers and supramolecular structures. Dalton Trans. 2008;4067-78.
34. Betancourt JE, Martin-Hidalgo M, Gubala V, Rivera JM. Solvent-induced high fidelity switching between two discrete supramolecules. J Am Chem Soc. 2009;131:3186-8.
35. Gubala V, Betancourt JE, Rivera JM. Expanding the Hoogsteen edge of 2′-deoxyguanosine: consequences for G-quadruplex formation. Org Lett. 2004;6(25):4735-8.
36. Wanninger-Weiss C, Valis L, Wagenknecht H-A. Pyrene-modified guanosine as fluorescent probe for DNA modulated by charge transfer. Bioorg Med Chem. 2008;16(1):100-6.
37. Lappchen T, Pinas VA, Hartog AF, Koomen G-J, Schaffner-Barbero C, Andreu JM, Trambaiolo D, Löwe J, Juhem A, Popov AV, den Blaauwen T. Probing FtsZ and tubulin with C8-substituted GTP analogs reveals differences in their nucleotide binding sites. Chem Biol. 2008;15:189-99.
38. Kohyama N, Katashima T, Yamamoto Y. Synthesis of Novel 2-Aryl AICAR Derivatives. Synthesis 2004, 2799-2804.
39. Shaughnessy KH, Booth RS. Sterically demanding, water-soluble alkylphosphines as ligands for high activity suzuki coupling of aryl bromides in aqueous solvents. Org Lett. 2001;3:2757-9.
40. Ikehara M, Tada H, Kaneko M. Studies of nucleosides and nucleotides-XXXV. Tetrahedron. 1968;24:3489-98.
41. Lipkin D, Howard FB, Nowotny D, Sano M. The iodination of nucleosides and nucleotides. J Biol Chem. 1963;238:2249-51.
42. Shaughnessy KH, Western EC, Gannett PM, Daft J, Johnson IEM. Efficient one-step Suzuki arylation of unprotected halonucleosides, using water-soluble palladium catalysts. J Org Chem. 2003;68:6767-74.
43. Western EC, Shaughnessy KH. Inhibitory effects of the guanine moiety on Suzuki couplings of unprotected halonucleosides in aqueous media. J Org Chem A. 2005;70:6378-88.
44. Gannett PM, Sura TP. An improved synthesis of 8-bromo-2′-deoxyguanosine. Synth Commun. 1993;23(11):1611-5.
45. Cerna I, Pohl R, Klepetarova B, Hocek M. Direct C-H arylation of purines: development of methodology and its use in regioselective synthesis of 2,6,8-trisubstituted purines. Org Lett. 2006;8:5389-92.
46. Cerna I, Pohl R, Hocek M. The first direct C-H arylation of purine nucleosides. Chem Commun. 2007;4729-30.
47. Storr TE, Baumann CG, Thatcher RJ, De Ornellas S, Whitwood AC, Fairlamb IJS. Pd(0)/Cu(I)-mediated direct arylation of 2′-deoxyadenosines: mechanistic role of Cu(I) and reactivity comparisons with related purine nucleosides. J Org Chem. 2009;74:5810-21.
48. Storr TE, Firth AG, Wilson K, Darley K, Baumann CG, Fairlamb IJS. Site-selective direct arylation of unprotected adenine nucleosides mediated by palladium and copper: insights into the reaction mechanism. Tetrahedron. 2008;64:6125-37.
49. Vongsutilers V, Gannett PM. A general synthesis of C8-arylpurine phosphoramidites. Molecules. 2009;14:3339-52.
50. Vu H, McCollum C, Jacobson K, Theisen P, Vinayak R, Spiess E, Andrus A. Fast oligonucleotide deprotection phosphoramidite chemistry for DNA synthesis. Tetrahed Lett. 1990;31:7269-72.
51. Sessler JL, Sathiosatham M, Doerr K, Lynch V, Abboud KA. A G-quartet formed in the absence of a templating metal cation: a new 8-(N,N-dimethylaniline)guanosine derivative. Angew Chem Int Ed. 2000;39:1300-3.
52. Piton N, Mu Y, Stock G, Prisner TF, Schiemann O, Engles JW. Base-specific spin-labeling of RNA for structure determination. Nucl Acids Res. 2007;35(9):3128-43.
53. Omumi A, Beach DG, Baker M, Gabryelski W, Manderville RA. Postsynthetic guanine arylation of DNA by Suzuki-Miyaura cross-coupling. J Am Chem Soc. 2011;133:42-50.
54. Koga K, Kurokawa M, Ochi M, Nakamura J, Kuwana Y. Adenosine A2A receptor antagonists KF1787 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats. Eur J Pharmacol. 2000;408:249-55.
55. Marie C, Maitre A, Douki T, Gateau M, Tarantini A, Guiraud P, Favier A, Ravanat J-L. Influence of the metabolic properties of human cells on the kinetics of formation of the major benzo[a]pyrene DNA adducts. J Appl Toxicol. 2007;28:579-90.
56. Faucet V, Pfohl-Leszkowicz A, Dai J, Castegnaro M, Manderville RA. Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem Res Toxicol. 2004;17:1289-96.
57. Powell JH, Gannett PM. Mechanisms of carcinogenicity of aryl hydrazines, aryl hydrazides, and arenediazonium ions. J Environ Pathol Toxicol Oncol. 2002;21(1):1-31.
58. Anderson CS, Broxton TJ. Reactions of aryl diazonium salts and arylazo alkyl ethers in basic alcoholic solvents. steric and mechanistic studies. J Org Chem. 1977;42:2454-8.
59. RamaKrishna NVS, Gao F, Padmavathi NS, Cavalieri E, Rogan EG, Cerny RL, Gross ML. Model adducts of benzo[a]pyrene and nucleosides formed from its radical cation and diol epoxide. Chem Res Toxicol. 1992;5:293-302.
60. Dai J, Wright MW, Manderville RA. Ochratoxin A forms a carbon-bonded C8-deoxyguanosine nucleoside adduct: implications for C8-reactivity by a phenolic radical. J Am Chem Soc. 2003;125:3716-7.
61. Gannett PM, Shi X, Lawson T, Kolar C, Toth B. Aryl radical formation during the metabolism of arylhydrazines by microsomes. Chem Res Toxicol. 1997;10(12):1372-7.
62. Huber R, Fiebig T, Wagenknecht H-A. Pyrene as a fluorescent probe for DNA base radicals. Chem Commun. 2003;1878-9.
63. Seo YJ, Kim BH. Probing the B-to-Z duplex transition using terminally stacking ethynyl pyrene-modified adenosine and uridine bases. J Chem Soc Chem Comm. 2006;150-2.
64. Collier A, Wagner GK. A fast synthetic route to GDP-sugars modified at the nucleobase. Chem Commun. 2008;(2):178-80.
65. Collier A, Wagner G. A facile two-step synthesis of 8-arylated guanosine mono-and triphosphates (8-aryl GXPs). Org Biomolec Chem. 2006;4:4526-32.
66. Sun KM, McLaughlin CK, Lantero DR, Manderville RA. Biomarkers for phenol carcinogen exposure act as pH-sensing fluorescent probes. J Am Chem Soc. 2007;129:1894-5.
67. Henderson ER, Moore M, Malcolm BA. Telomere G-strand structure and function analyzed by chemical protection, base analogue substitution, and utilization by telomerase in vitro. Biochemistry. 1990;29:732-7.
68. Blackburn EH. Telomerases. Ann Rev Biochem. 1992;61:113-29.
69. Gubala V, De Jesus D, Rivera JM. Self-assembled ionophores based on 8-phenyl-2′-deoxyguanosine analogues. Tetrahed Lett. 2006;47:1413-6.
70. Garcia-Arriaga M, Hobley G, Rivera JM. Isostructural self-assembly of 2′-deoxyguanosine derivatives in aqueous and organic media. J Am Chem Soc. 2008;130:10492-3.
71. Davis JT. G-quartets 40 years later: from 5′-GMP to molecular biology and supramolecular chemistry. Angew Chem Internat Ed Eng. 2004;43:668-98.
72. Takeuchi T, Morimoto K. Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency. Carcinogenesis. 1993;14:1115-20.
73. Daly JW, Padgett W, Shamim MT, Butts-Lamb P, Waters J. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for Al-and A2-adenosine receptors. J Med Chem. 1989;28:487-97.
74. Jacobson KA, Kirk KL, Padgett WL, Daly JW. Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors. J Med Chem. 1985;28:1334-40.
75. Bruns RF, Daly JW, Snyder SH. Adenosine receptor binding: structure-activity analysis generates extremely potent xanthine antagonists. Proc Natl Acad Sci USA. 1983;80:2077-80.
76. Kenyon CP, Oldfield LC, Van Der Westhuyzen CW, Amanda L, Parkinson CJ, inventors; Modulation of phosphoryl transferase activity of glutamine synthetase. United Kingdom, GB 2451594A, 2009, 02, 04.
77. Arsenyan P, Ikaunieks M, Belyakov S. Stille coupling approaches for the synthesis of 8-aryl guanines. Tetrahed Lett. 2007;48:961-4.
78. Capek P, Pohl R, Hocek M. Cross-coupling reactions of unprotected halopurine bases, nucleosides, nucleotides and nucleoside triphosphates with 4-boronophenylalanine in water. Synthesis of (purin-8-yl)-and (purin-6-yl)phenylalanines. Org Biomolec Chem. 2006;4(11):2278-84.
79. Collier A, Wagner GK. Suzuki-Miyaura cross-coupling of unprotected halopurine nucleosides in water-influence of catalyst and cosolvent. Synth Commun. 2006;36(24):3713-21.